Literature DB >> 23567336

Comprehensive analysis of expression profile reveals the ubiquitous distribution of PPPDE peptidase domain 1, a Golgi apparatus component, and its implications in clinical cancer.

Yi He1, Jiangman Wang, Lantu Gou, Congcong Shen, Liangyin Chen, Cheng Yi, Xian Wei, Jinliang Yang.   

Abstract

PPPDE peptidase domain 1 (PPPDE1) is a recently identified gene; however, its expression regulation and biological function are unclear. Previous studies have indicated that PPPDE1 is involved in embryogenesis, apoptosis induction and cell cycle regulation. In the present study, we first used an anti-PPPDE1 antibody to determine that endogenous PPPDE1 is located in the Golgi apparatus. Immunohistochemistry (IHC) of mouse embryos indicated that PPPDE1 was markedly distributed in liver, skin, intestinal villi, and muscles, whereas Western blot analysis of mouse mature organs revealed its ubiquitous expression, without an appreciable distinction in protein abundance. Surprisingly, another potential isoform of PPPDE1 with a molecular weight of 18 kD (rather than its predicted molecular weight of 21 kD) was detected in the mouse kidney, testis, and intestine. Moreover, microarrays that were derived from twelve tumor types revealed that PPPDE1 expression was significantly lower in pancreas, stomach, and skin tumors compared with normal tissue from these organs. We specifically and extensively analyzed PPPDE1 expression in clinical samples and observed strong associations between PPPDE1 expression and (i) differentiation grade in pancreatic ductal adenocarcinoma and (ii) T stage in skin squamous cell carcinoma. Our data are the first to reveal the expression profile of PPPDE1 protein and its implications in cancer. These results will contribute to the understanding of the expression regulation and biological functions of PPPDE1 in development and carcinogenesis.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23567336     DOI: 10.1016/j.biochi.2013.03.013

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  5 in total

1.  Analysis of transcription profile to reveal altered signaling pathways following the overexpression of human desumoylating isopeptidase 2 in pancreatic cancer cells.

Authors:  Yu-Yin Fu; Yu-Huan Kang; Cong-Cong Shen; Rui-Xue Wang; Lin Yu; Xin-Yue Li; Dan-Dan Cui; Jin-Liang Yang; Yu-Qin Yao; Lan-Tu Gou
Journal:  Oncol Lett       Date:  2016-10-19       Impact factor: 2.967

2.  High Phosphorylation Status of AKT/mTOR Signal in DESI2-Reduced Pancreatic Ductal Adenocarcinoma.

Authors:  Cong-Cong Shen; Xin-Yi Cui; Yi He; Yu-Huan Kang; Cheng Yi; Jin-Liang Yang; Lan-Tu Gou
Journal:  Pathol Oncol Res       Date:  2014-07-31       Impact factor: 3.201

3.  Non-TZF Protein AtC3H59/ZFWD3 Is Involved in Seed Germination, Seedling Development, and Seed Development, Interacting with PPPDE Family Protein Desi1 in Arabidopsis.

Authors:  Hye-Yeon Seok; Hyungjoon Bae; Taehyoung Kim; Syed Muhammad Muntazir Mehdi; Linh Vu Nguyen; Sun-Young Lee; Yong-Hwan Moon
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

4.  Implications of PPPDE1 expression in the distribution of plakoglobin and β-catenin in pancreatic ductal adenocarcinoma.

Authors:  Yu-Huan Kang; Cong-Cong Shen; Yu-Qin Yao; Lin Yu; Xin-Yi Cui; Yi He; Jin-Liang Yang; Lan-Tu Gou
Journal:  Oncol Lett       Date:  2014-06-24       Impact factor: 2.967

5.  Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.

Authors:  Xi Liu; Lei Chen; Tao Zhang
Journal:  Cancer Control       Date:  2018 Jan-Mar       Impact factor: 3.302

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.